Treatment of severe Raynaud's phenomenon with bosentan in a patient with systemic sclerosis

被引:6
作者
Dunne, J. [1 ]
Dutz, J.
Shojania, K.
Ng, B.
van Eeden, S.
机构
[1] Univ British Columbia, St Pauls Hosp, Dept Med, Vancouver, BC V5Z 1M9, Canada
[2] Capture Ctr Cardiovasc & Pulm Res, Vancouver, BC, Canada
关键词
D O I
10.1093/rheumatology/kei129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:911 / 912
页数:2
相关论文
共 10 条
[1]   Circulating endothelial cells and vascular injury in systemic lupus erythematosus. [J].
Clancy R.M. .
Current Rheumatology Reports, 2000, 2 (1) :39-43
[2]   Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis [J].
Del Papa, N ;
Colombo, G ;
Fracchiolla, N ;
Moronetti, LM ;
Ingegnoli, F ;
Maglione, W ;
Comina, DP ;
Vitali, C ;
Fantini, F ;
Cortelezzi, A .
ARTHRITIS AND RHEUMATISM, 2004, 50 (04) :1296-1304
[3]   Circulating endothelial cells in vascular disorders: new insights into an old concept [J].
Dignat-George, F ;
Sampol, J .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (04) :215-220
[4]   Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients [J].
Ferri, C ;
Valentini, G ;
Cozzi, F ;
Sebastiani, M ;
Michelassi, C ;
La Montagna, G ;
Bullo, A ;
Cazzato, M ;
Tirri, E ;
Storino, F ;
Giuggioli, D ;
Cuomo, G ;
Rosada, M ;
Bombardieri, S ;
Todesco, S ;
Tirri, G .
MEDICINE, 2002, 81 (02) :139-153
[5]   Circulating endothelial progenitor cells, vascular function, and cardiovascular risk [J].
Hill, JM ;
Zalos, G ;
Halcox, JPJ ;
Schenke, WH ;
Waclawiw, MA ;
Quyyumi, AA ;
Finkel, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :593-600
[6]   Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan [J].
Humbert, M ;
Cabane, J .
RHEUMATOLOGY, 2003, 42 (01) :191-193
[7]   Digital ulcers in systemic sclerosis - Prevention by treatment with bosentan, an oral endothelin receptor antagonist [J].
Korn, JH ;
Mayes, M ;
Cerinic, MM ;
Rainisio, M ;
Pope, J ;
Hachulla, E ;
Rich, E ;
Carpentier, P ;
Molitor, J ;
Seibold, JR ;
Hsu, V ;
Guillevin, L ;
Chatterjee, S ;
Peter, HH ;
Coppock, J ;
Herrick, A ;
Merkel, PA ;
Simms, R ;
Denton, CP ;
Furst, D ;
Nguyen, N ;
Gaitonde, M ;
Black, C .
ARTHRITIS AND RHEUMATISM, 2004, 50 (12) :3985-3993
[8]   Successful treatment of severe Raynaud's phenomenon with bosentan in four patients with systemic sclerosis [J].
Ramos-Casals, M ;
Brito-Zerón, P ;
Nardi, N ;
Claver, G ;
Risco, G ;
Parraga, FD ;
Fernandez, S ;
Julià, M ;
Font, J .
RHEUMATOLOGY, 2004, 43 (11) :1454-1456
[9]   Circulating activated endothelial cells in sickle cell anemia [J].
Solovey, A ;
Lin, Y ;
Browne, P ;
Choong, S ;
Wayner, E ;
Hebbel, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (22) :1584-1590
[10]   Raynaud's phenomenon [J].
Wigley, FM ;
Flavahan, NA .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1996, 22 (04) :765-&